WHO ICTRP trial
A phase I/II trial to compare the immunogenicity and safety of three DNA C prime…
ISRCTN20946776 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN20946776 |
|---|---|
| Public title | A phase I/II trial to compare the immunogenicity and safety of three DNA C prime followed by one NYVAC C boost to two DNA C prime followed by two NYVAC C boost |
| Scientific title | A phase I/II trial to compare the immunogenicity and safety of three DNA C prime followed by one NYVAC C boost to two DNA C prime followed by two NYVAC C boost |
| Primary sponsor | EuroVacc Foundation (Switzerland) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase I/II |
| Countries | France;Germany;Switzerland;United Kingdom |
| Conditions | HIV prophylaxis Infections and Infestations HIV |
| Interventions | Group 1: 3 x DNA HIV-C (2 x 2 ml IntraMuscular [IM] at weeks 0, 4 and 8 in right and left vastus lateralis) followed by NYVAC HIV-C (1 ml IM at week 24 in non-dominant deltoid) Group 2: 2 x DNA HIV-C (2 x 2 ml IM at weeks 0 and 4 in right… |
| Registration date | Jun 29, 2007 |
| Target size | 140 |
| Secondary IDs | NCT00490074;EV03 / ANRS Vac20 |
| Registry page | isrctn.com |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: